Nucleo Life Sciences Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 3

Nucleo Life Sciences General Information

Description

Developer of pharmaceutical products intended to help patients by developing innovative therapies into commercially viable products. The company offers pre-formulation and formulation development, process development, analytical development, method transfer as well as scale-up services, enabling its clients to take their drugs to the market quickly and effectively.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • 27 Jordan Street
  • San Rafael, CA 94901
  • United States
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Corporate Office
  • 27 Jordan Street
  • San Rafael, CA 94901
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nucleo Life Sciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Nucleo Life Sciences‘s full profile, request access.

Request a free trial

Nucleo Life Sciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of pharmaceutical products intended to help patients by developing innovative therapies into commercially viab
Drug Discovery
San Rafael, CA
13 As of 2021

Waltham, MA
 

Mumbai, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nucleo Life Sciences Competitors (27)

One of Nucleo Life Sciences’s 27 competitors is Ardelyx, a Formerly VC-backed company based in Waltham, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ardelyx Formerly VC-backed Waltham, MA
Cipla Corporation Mumbai, India
CSL Behring (Biotechnology) Corporation Vienna, Austria
Glenmark Pharmaceuticals Corporation Mumbai, India
Pharmaceutics International Formerly PE-Backed MD
You’re viewing 5 of 27 competitors. Get the full list »

Nucleo Life Sciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nucleo Life Sciences Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Nucleo Life Sciences‘s full profile, request access.

Request a free trial

Nucleo Life Sciences FAQs

  • When was Nucleo Life Sciences founded?

    Nucleo Life Sciences was founded in 2014.

  • Where is Nucleo Life Sciences headquartered?

    Nucleo Life Sciences is headquartered in San Rafael, CA.

  • What is the size of Nucleo Life Sciences?

    Nucleo Life Sciences has 13 total employees.

  • What industry is Nucleo Life Sciences in?

    Nucleo Life Sciences’s primary industry is Drug Discovery.

  • Is Nucleo Life Sciences a private or public company?

    Nucleo Life Sciences is a Private company.

  • What is Nucleo Life Sciences’s current revenue?

    The current revenue for Nucleo Life Sciences is .

  • Who are Nucleo Life Sciences’s investors?

    MBC BioLabs and QB3 have invested in Nucleo Life Sciences.

  • Who are Nucleo Life Sciences’s competitors?

    Ardelyx, Cipla, CSL Behring (Biotechnology), Glenmark Pharmaceuticals, and Pharmaceutics International are some of the 27 competitors of Nucleo Life Sciences.

  • When was Nucleo Life Sciences acquired?

    Nucleo Life Sciences was acquired on 24-May-2021.

  • Who acquired Nucleo Life Sciences?

    Nucleo Life Sciences was acquired by Bend Bioscience (Formerly CoreRx).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process